YMAB insider buying & filings

YMABY-mAbs Therapeutics, Inc.

—

29 insider filings on record.
None of them an open-market buy in the last year.

Last Form 4 Sep 19 · scanned 5m ago

No price data yet — the yfinance scanner hasn't produced bars for YMAB.

AI brief · from the filings on this pagePro

The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.

Short % float

Pro

The record

newest first

DateTypeInsiderOf stakeShares @ priceValue

Sep 19RETURNHamill LauraDirectordirect25,080 sh—

Sep 19OTHERHamill LauraDirectordirect5,825 @ $8.60$50.1K

Sep 18RETURNWilms JorisSVP & CHIEF OPERATING OFFICERdirect39,301 sh—

Sep 18OTHERWilms JorisSVP & CHIEF OPERATING OFFICERdirect12,799 @ $8.60$110.1K

Sep 18OTHERWedell-Wedellsborg Johan10% ownerindirect4,559,233 @ $8.60$39.21M

The file stays open

▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice